| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 5 | 73,391 | HIMS, THRX, IRON, KNTE | 13F-HR | 2/13/2024 | 000110465924019707 |
| Q3 2023 | 7 | 62,679 | HIMS, IRON, THRX, ACRS | 13F-HR | 11/13/2023 | 000110465923117294 |
| Q2 2023 | 10 | 136,901 | HIMS, THRX, PRDS, ACRS | 13F-HR | 8/11/2023 | 000110465923090058 |
| Q1 2023 | 11 | 135,274 | HIMS, THRX, PRDS, KNTE | 13F-HR | 5/12/2023 | 000110465923059499 |
| Q4 2022 | 11 | 128,750 | HIMS, CMPX, ACRS, THRX | 13F-HR | 2/13/2023 | 000110465923019781 |
| Q3 2022 | 14 | 130,057 | ACRS, THRX, HIMS, PRDS | 13F-HR | 11/14/2022 | 000110465922117993 |
| Q2 2022 | 14 | 143,141 | PRDS, THRX, ACRS, SLGC | 13F-HR | 8/12/2022 | 000110465922089769 |
| Q1 2022 | 17 | 244,877 | PRDS, THRX, SLGC, ACRS | 13F-HR | 5/13/2022 | 000110465922059939 |
| Q4 2021 | 16 | 407,014 | PRDS, SLGC, THRX, QSI | 13F-HR | 2/11/2022 | 000110465922020352 |
| Q3 2021 | 17 | 321,757 | SLGC, CGEM, IVVD, ACRS | 13F-HR | 11/12/2021 | 000110465921137703 |
| Q2 2021 | 17 | 254,189 | CGEM, QSI, ACRS, KNTE | 13F-HR | 8/16/2021 | 000110465921105290 |
| Q1 2021 | 20 | 340,170 | CGEM, Gemini Therapeutics, Inc., ACRS, KNTE | 13F-HR | 5/17/2021 | 000110465921067104 |
| Q4 2020 | 12 | 135,028 | KNTE, ALXO, RLAY, NRIX | 13F-HR | 2/16/2021 | 000110465921023088 |